Mildly Increased 68 Ga-Pentixafor Uptake in Hepatic Hemangioma.

IF 9.6 3区医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Clinical Nuclear Medicine Pub Date : 2024-12-01 Epub Date: 2024-10-10 DOI:10.1097/RLU.0000000000005484

Lixiang Yang, Mingxing Huang, Rong Tian, Qianrui Li

引用次数: 0

Abstract

Abstract: 68 Ga-pentixafor uptake in hemangioma is rare. We report 68 Ga-pentixafor PET/MRI findings of a hepatic hemangioma in a 54-year-old woman. The images revealed a hyperintense lesion in the right posterior liver on T2-weighted images, with mild pentixafor uptake. The lesion was consistent with typical presentations of a hemangioma on MRI and contrast-enhanced CT.

查看原文本刊更多论文

肝血管瘤的 68Ga-Pentixafor 摄取轻度增加

摘要：68Ga-pentixafor在血管瘤中的摄取非常罕见。我们报告了一名 54 岁女性肝血管瘤的 68Ga-pentixafor PET/MRI 发现。图像显示，在 T2 加权图像上，肝脏右后方有一个高张力病灶，伴有轻度 pentixafor 摄取。该病灶在核磁共振成像和对比增强 CT 上与典型的血管瘤表现一致。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Nuclear Medicine 医学-核医学

CiteScore

2.90

自引率

31.10%

发文量

1113

审稿时长

2 months

期刊介绍： Clinical Nuclear Medicine is a comprehensive and current resource for professionals in the field of nuclear medicine. It caters to both generalists and specialists, offering valuable insights on how to effectively apply nuclear medicine techniques in various clinical scenarios. With a focus on timely dissemination of information, this journal covers the latest developments that impact all aspects of the specialty. Geared towards practitioners, Clinical Nuclear Medicine is the ultimate practice-oriented publication in the field of nuclear imaging. Its informative articles are complemented by numerous illustrations that demonstrate how physicians can seamlessly integrate the knowledge gained into their everyday practice.